Concepedia

Nisar A. Baig

NA

Statistics

Publications

4

Citations

183

H-Index

4

Active since

2012

Affiliations

University of Virginia(Current)

Mayo Clinic in Arizona

Mayo Clinic in Florida

Nisar A. Baig is an author at University of Virginia specializing in cancer immunotherapy, immunology, and chronic lymphocytic leukemia therapy.

Publications per year

2012–2015

4

Publications

4

Induced Resistance to Ofatumumab-Mediated Cell Clearance Mechanisms, Including Complement-Dependent Cytotoxicity, in Chronic Lymphocytic Leukemia

Nisar A. Baig, Ronald P. Taylor, Margaret A. Lindorfer et al. · The Journal of Immunology · 2014 · 53 citations · Full text

Pharmacy, Immunology, Oncology +17

Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages

Amy K. Church, Karl R. VanDerMeid, Nisar A. Baig et al. · Clinical & Experimental Immunology · 2015 · 50 citations · Full text

Pharmacy, Hematology, Immunology +17

Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement

Nisar A. Baig, Ronald P. Taylor, Margaret A. Lindorfer et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 45 citations · Full text

Life Sciences, Immunology, Oncology +17

Chemoimmunotherapy for relapsed/refractory and progressive 17p13‐deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low‐dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells

Clive S. Zent, Ronald P. Taylor, Margaret A. Lindorfer et al. · American Journal of Hematology · 2014 · 35 citations · Full text

Medicine, Immunology, Oncology +13

1–4 of 4